Philipp Schwabl

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension.

Petrenko O, Königshofer P, Brusilovskaya K, Hofer BS, Bareiner K, Simbrunner B, Jühling F, Baumert TF, Lupberger J, Trauner M, Kauschke SG, Pfisterer L, Simon E, Rendeiro AF, de Rooij LPMH, Schwabl P, Reiberger T.

iScience. 2024 Mar 15. 27(3):109301. PMID: 38469563

FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence.

Simbrunner B, Hofer BS, Schwabl P, Zinober K, Petrenko O, Fuchs C, Semmler G, Marculescu R, Mandorfer M, Datz C, Trauner M, Reiberger T.

Hepatol Int. 2024 Feb 08. PMID: 38332428

Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana.

Vanhove M, Schwabl P, Clementson C, Early AM, Laws M, Anthony F, Florimond C, Mathieu L, James K, Knox C, Singh N, Buckee CO, Musset L, Cox H, Niles-Robin R, Neafsey DE.

bioRxiv. 2024 Feb 01. PMID: 38352461

Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist.

Castillo GM, Yao Y, Guerra RE, Jiang H, Nishimoto-Ashfield A, Lyubimov AV, Alfaro JF, Striker KA, Buynov N, Schwabl P, Bolotin EM.

Biomed Pharmacother. 2024 Feb. 171:116068. PMID: 38176129

Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis.

Hofer BS, Brusilovskaya K, Simbrunner B, Balcar L, Eichelberger B, Lee S, Hartl L, Schwabl P, Mandorfer M, Panzer S, Reiberger T, Gremmel T.

Hepatology. 2023 Dec 27. PMID: 38150294

Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.

Simbrunner B, Villesen IF, Scheiner B, Paternostro R, Schwabl P, Stättermayer AF, Marculescu R, Pinter M, Quehenberger P, Trauner M, Karsdal M, Lisman T, Reiberger T, Leeming DJ, Mandorfer M.

Hepatol Int. 2023 Dec. 17(6):1532-1544. PMID: 37605068

Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation.

Paternostro R, Jachs M, Hartl L, Simbrunner B, Scheiner B, Bauer D, Schwabl P, Semmler G, Trauner M, Mandorfer M, Reiberger T.

Aliment Pharmacol Ther. 2023 10. 58(8):805-813. PMID: 37519146

Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study.

Brusilovskaya K, Hofer BS, Simbrunner B, Eichelberger B, Lee S, Bauer DJM, Mandorfer M, Schwabl P, Panzer S, Reiberger T, Gremmel T.

Thromb Haemost. 2023 Dec. 123(12):1140-1150. PMID: 37517407

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis.

Hofer BS, Simbrunner B, Hartl L, Jachs M, Balcar L, Paternostro R, Schwabl P, Semmler G, Scheiner B, Trauner M, Mandorfer M, Reiberger T.

Liver Int. 2023 10. 43(10):2220-2231. PMID: 37469291

Correction: Vector mapping and bloodmeal metabarcoding demonstrate risk of urban Chagas disease transmission in Caracas, Venezuela.

Segovia M, Schwabl P, Sueto S, Nakad CC, Londoño JC, Rodriguez M, Paiva M, Llewellyn MS, Carrasco HJ.

PLoS Negl Trop Dis. 2023 Jul. 17(7):e0011489. PMID: 37450429